JP2007169302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007169302A5 JP2007169302A5 JP2007083117A JP2007083117A JP2007169302A5 JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5 JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5
- Authority
- JP
- Japan
- Prior art keywords
- oligosaccharide conjugate
- menc
- hib
- sequential administration
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001542 oligosaccharide Polymers 0.000 claims 5
- 150000002482 oligosaccharides Chemical class 0.000 claims 5
- 229940014135 meningitis vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9422096A GB9422096D0 (en) | 1994-11-02 | 1994-11-02 | Combined meningitis vaccine |
| GB9422096.9 | 1994-11-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51517596A Division JP3989951B2 (ja) | 1994-11-02 | 1995-11-02 | 組み合わせ髄膜炎ワクチン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010236921A Division JP2011016850A (ja) | 1994-11-02 | 2010-10-21 | 組み合わせ髄膜炎ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007169302A JP2007169302A (ja) | 2007-07-05 |
| JP2007169302A5 true JP2007169302A5 (cg-RX-API-DMAC7.html) | 2007-08-16 |
| JP4871770B2 JP4871770B2 (ja) | 2012-02-08 |
Family
ID=10763774
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51517596A Expired - Fee Related JP3989951B2 (ja) | 1994-11-02 | 1995-11-02 | 組み合わせ髄膜炎ワクチン |
| JP2007083117A Expired - Fee Related JP4871770B2 (ja) | 1994-11-02 | 2007-03-27 | 組み合わせ髄膜炎ワクチン |
| JP2010236921A Withdrawn JP2011016850A (ja) | 1994-11-02 | 2010-10-21 | 組み合わせ髄膜炎ワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51517596A Expired - Fee Related JP3989951B2 (ja) | 1994-11-02 | 1995-11-02 | 組み合わせ髄膜炎ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010236921A Withdrawn JP2011016850A (ja) | 1994-11-02 | 2010-10-21 | 組み合わせ髄膜炎ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6251401B1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2204185A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP3989951B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE246936T1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2204277C (cg-RX-API-DMAC7.html) |
| CY (1) | CY2423B1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69531501T3 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0789587T4 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2204967T5 (cg-RX-API-DMAC7.html) |
| GB (1) | GB9422096D0 (cg-RX-API-DMAC7.html) |
| PT (1) | PT789587E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1996014086A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9422096D0 (en) * | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
| US6048527A (en) * | 1996-08-27 | 2000-04-11 | Chiron Corporation | Antibodies that define unique Meningococcal B epitopes and vaccine compositions |
| DE69708318T3 (de) | 1996-08-27 | 2006-11-16 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung |
| JP2002508748A (ja) * | 1997-05-01 | 2002-03-19 | カイロン コーポレイション | アジュバントとしてのウイルス様粒子の使用 |
| US20040087020A1 (en) | 1997-05-28 | 2004-05-06 | Chiron S.P.A. | Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
| EP1849860B1 (en) * | 1997-05-28 | 2010-11-17 | Novartis Vaccines and Diagnostics S.r.l. | Process for preparing an immunogenic factor of Corynebacterium diphtheriae using a culture medium with yeast extract as aminoacid source and no protein complexes of animal origin |
| US20070259007A1 (en) * | 1999-10-19 | 2007-11-08 | Kruzel Marian L | Lactoferrin: an adjuvant for vaccines |
| EP1233784B1 (en) * | 1999-12-02 | 2008-07-09 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for stabilizing biological molecules upon lyophilization |
| WO2002000249A2 (en) * | 2000-06-29 | 2002-01-03 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine composition |
| GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| JP2004529643A (ja) | 2001-04-17 | 2004-09-30 | カイロン コーポレイション | 機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物 |
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| DE60328481D1 (de) * | 2002-05-14 | 2009-09-03 | Novartis Vaccines & Diagnostic | Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält |
| GB0302218D0 (en) * | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| US20030124139A1 (en) * | 2002-11-20 | 2003-07-03 | Irina Esikova | Compositions and methods for stabilizing biological molecules upon lyophilization |
| CN102302776B (zh) | 2003-01-30 | 2014-06-18 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
| US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
| CN103405761A (zh) | 2003-10-02 | 2013-11-27 | 诺华疫苗和诊断有限公司 | 多种脑膜炎球菌血清群的液体疫苗 |
| GB0500787D0 (en) * | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| DK2283857T3 (da) | 2005-06-27 | 2019-10-28 | Glaxosmithkline Biologicals Sa | Vaccinesammensætning omfattende konjugerede native N. Meningitidis kapselpolysaccharider |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| ES2555786T3 (es) * | 2007-06-04 | 2016-01-08 | Glaxosmithkline Biologicals Sa | Formulación de vacunas contra la meningitis |
| ATE553774T1 (de) * | 2007-10-19 | 2012-05-15 | Novartis Ag | Meningokokkenimpfstoffformulierungen |
| JP2011506334A (ja) | 2007-12-07 | 2011-03-03 | ノバルティス アーゲー | 免疫応答を誘導するための組成物 |
| FI2608805T4 (fi) | 2010-08-23 | 2025-08-07 | Wyeth Llc | NEISSERIA MENINGITIDIS rLP2086 -ANTIGEENIEN STABIILEJA FORMULAATIOITA |
| CA2809758C (en) | 2010-09-10 | 2021-07-13 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
| MX351993B (es) | 2012-03-09 | 2017-11-03 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
| MX380129B (es) | 2013-09-08 | 2025-03-11 | Pfizer | Composiciones de neisseria meningitidis y sus metodos |
| CN107249626A (zh) | 2015-02-19 | 2017-10-13 | 辉瑞大药厂 | 脑膜炎奈瑟球菌组合物及其方法 |
| IL267733B2 (en) | 2017-01-31 | 2023-10-01 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| MX2022003682A (es) | 2019-09-27 | 2022-04-25 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) * | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4451446A (en) * | 1982-03-04 | 1984-05-29 | Smithkline-Rit | Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them |
| US4619828A (en) * | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
| US4459286A (en) * | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
| US5371197A (en) * | 1991-09-24 | 1994-12-06 | Merck & Co., Inc. | Protein-dimeric polysaccharide conjugate vaccine |
| GB9202219D0 (en) * | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
| IT1262896B (it) * | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| GB9422096D0 (en) * | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
| US5628496A (en) | 1995-06-07 | 1997-05-13 | Avm, Inc. | Pneumatic spring |
| US6048527A (en) * | 1996-08-27 | 2000-04-11 | Chiron Corporation | Antibodies that define unique Meningococcal B epitopes and vaccine compositions |
-
1994
- 1994-11-02 GB GB9422096A patent/GB9422096D0/en active Pending
-
1995
- 1995-11-02 PT PT95935550T patent/PT789587E/pt unknown
- 1995-11-02 EP EP10075114A patent/EP2204185A1/en not_active Withdrawn
- 1995-11-02 WO PCT/IB1995/001006 patent/WO1996014086A1/en not_active Ceased
- 1995-11-02 EP EP95935550A patent/EP0789587B2/en not_active Expired - Lifetime
- 1995-11-02 CA CA002204277A patent/CA2204277C/en not_active Expired - Fee Related
- 1995-11-02 JP JP51517596A patent/JP3989951B2/ja not_active Expired - Fee Related
- 1995-11-02 DK DK95935550T patent/DK0789587T4/da active
- 1995-11-02 AT AT95935550T patent/ATE246936T1/de active
- 1995-11-02 ES ES95935550T patent/ES2204967T5/es not_active Expired - Lifetime
- 1995-11-02 DE DE69531501T patent/DE69531501T3/de not_active Expired - Lifetime
- 1995-11-02 EP EP03075069A patent/EP1312377A3/en not_active Withdrawn
- 1995-11-02 US US08/836,080 patent/US6251401B1/en not_active Expired - Lifetime
- 1995-11-02 CA CA2689871A patent/CA2689871A1/en not_active Abandoned
-
2004
- 2004-01-30 CY CY0400008A patent/CY2423B1/xx unknown
-
2007
- 2007-03-27 JP JP2007083117A patent/JP4871770B2/ja not_active Expired - Fee Related
-
2010
- 2010-10-21 JP JP2010236921A patent/JP2011016850A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007169302A5 (cg-RX-API-DMAC7.html) | ||
| JP2006213929A5 (cg-RX-API-DMAC7.html) | ||
| IL222346A (en) | An immunogenic preparation containing at least two capsular sugars of meningitides n, its use and a vaccine containing it | |
| JP2009524695A5 (cg-RX-API-DMAC7.html) | ||
| ATE520415T1 (de) | Pneumokokken-polysaccharid-konjugat-vakzine | |
| DK1868645T3 (da) | Multivalent pneumokok-sakkarid-protein-konjugat-sammensætning | |
| JP2007522094A5 (cg-RX-API-DMAC7.html) | ||
| DK2051975T3 (da) | Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel. | |
| IL203915A (en) | Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol | |
| JP2007533729A5 (cg-RX-API-DMAC7.html) | ||
| JP2009536652A5 (cg-RX-API-DMAC7.html) | ||
| JP2009538898A5 (cg-RX-API-DMAC7.html) | ||
| IL200388A (en) | Antibody, antibody hybridoma, antibody-containing conjugate, antibody-containing drug and / or conjugate and their uses | |
| JP2007520565A5 (cg-RX-API-DMAC7.html) | ||
| JP2006305390A5 (cg-RX-API-DMAC7.html) | ||
| WO2007083190A3 (en) | Water insoluble helichrysum extract, process for preparing the same and uses thereof | |
| JP2008104450A5 (cg-RX-API-DMAC7.html) | ||
| EP2076125A4 (en) | MODIFIED NDGA DERIVATIVES FROM TETRA-O-SUBSTITUTED BUTANE BRIDGE, THEIR SYNTHESIS AND PHARMACEUTICAL USE | |
| JP2008519810A5 (cg-RX-API-DMAC7.html) | ||
| EP2292241A4 (en) | SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE | |
| ATE466863T1 (de) | Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit | |
| EA200901387A1 (ru) | Фармацевтическая композиция, включающая дезлоратадин | |
| JP2009509934A5 (cg-RX-API-DMAC7.html) | ||
| DE602006018617D1 (de) | Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten | |
| During | SUPER HOT |